Iguana Healthcare Management as of Dec. 31, 2016
Portfolio Holdings for Iguana Healthcare Management
Iguana Healthcare Management holds 60 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical (RARE) | 6.7 | $11M | 160k | 70.31 | |
| Biogen Idec (BIIB) | 5.9 | $9.9M | 35k | 283.57 | |
| Medicines Company | 5.6 | $9.3M | 275k | 33.94 | |
| Celgene Corporation | 5.5 | $9.3M | 80k | 115.75 | |
| Amgen (AMGN) | 4.4 | $7.3M | 50k | 146.22 | |
| Alexion Pharmaceuticals | 4.0 | $6.7M | 55k | 122.35 | |
| Merck & Co (MRK) | 3.9 | $6.5M | 110k | 58.87 | |
| Zimmer Holdings (ZBH) | 3.1 | $5.2M | 50k | 103.20 | |
| NuVasive | 2.8 | $4.7M | 70k | 67.36 | |
| Dermira | 2.7 | $4.5M | 150k | 30.33 | |
| Abbott Laboratories (ABT) | 2.6 | $4.4M | 115k | 38.41 | |
| Aerie Pharmaceuticals | 2.6 | $4.4M | 115k | 37.85 | |
| Oncomed Pharmaceuticals | 2.5 | $4.2M | 550k | 7.71 | |
| Glaukos (GKOS) | 2.5 | $4.1M | 120k | 34.30 | |
| Mazor Robotics Ltd. equities | 2.3 | $3.8M | 175k | 21.92 | |
| Ishares Tr Index option | 2.0 | $3.4M | 25k | 134.84 | |
| Cigna Corp | 2.0 | $3.3M | 25k | 133.40 | |
| Clovis Oncology | 2.0 | $3.3M | 75k | 44.43 | |
| Merus N V (MRUS) | 1.9 | $3.2M | 150k | 21.11 | |
| K2m Group Holdings | 1.8 | $3.0M | 150k | 20.04 | |
| Alder Biopharmaceuticals | 1.7 | $2.9M | 140k | 20.80 | |
| Walgreen Boots Alliance (WBA) | 1.7 | $2.9M | 35k | 82.77 | |
| Anthem (ELV) | 1.7 | $2.9M | 20k | 143.75 | |
| Spectranetics Corporation | 1.6 | $2.7M | 110k | 24.50 | |
| Allergan | 1.6 | $2.6M | 13k | 210.00 | |
| Supernus Pharmaceuticals (SUPN) | 1.5 | $2.5M | 100k | 25.25 | |
| Global Blood Therapeutics In | 1.5 | $2.5M | 175k | 14.45 | |
| Healthways | 1.4 | $2.3M | 100k | 22.75 | |
| Walgreens Boots Alliance | 1.2 | $2.1M | 25k | 82.76 | |
| Chemocentryx | 1.2 | $2.0M | 270k | 7.40 | |
| Regeneron Pharmaceuticals (REGN) | 1.1 | $1.8M | 5.0k | 367.13 | |
| Gilead Sciences (GILD) | 1.1 | $1.8M | 25k | 71.60 | |
| Minerva Neurosciences | 1.1 | $1.8M | 150k | 11.75 | |
| Advanced Accelerat spon ads each rep 2 ord | 1.0 | $1.6M | 60k | 26.77 | |
| Acceleron Pharma | 0.9 | $1.5M | 60k | 25.52 | |
| Mylan Nv | 0.9 | $1.5M | 40k | 38.15 | |
| Boston Scientific Corporation (BSX) | 0.8 | $1.4M | 65k | 21.63 | |
| AstraZeneca (AZN) | 0.8 | $1.4M | 50k | 27.32 | |
| LHC | 0.8 | $1.4M | 30k | 45.70 | |
| Astrazeneca Plc option | 0.8 | $1.4M | 50k | 27.32 | |
| Aclaris Therapeutics (ACRS) | 0.8 | $1.4M | 50k | 27.14 | |
| Dex (DXCM) | 0.7 | $1.2M | 20k | 59.70 | |
| Immunomedics | 0.7 | $1.1M | 300k | 3.67 | |
| Intersect Ent | 0.5 | $908k | 75k | 12.11 | |
| Array BioPharma | 0.5 | $879k | 100k | 8.79 | |
| Spdr S&p Oil & Gas Exp & Pr call | 0.5 | $888k | 15k | 59.20 | |
| Scynexis | 0.5 | $798k | 250k | 3.19 | |
| Horizon Pharma | 0.5 | $809k | 50k | 16.18 | |
| Ra Pharmaceuticals | 0.5 | $760k | 50k | 15.20 | |
| Achaogen | 0.4 | $651k | 50k | 13.02 | |
| Diplomat Pharmacy | 0.4 | $630k | 50k | 12.60 | |
| Allscripts Healthcare Solutions (MDRX) | 0.4 | $613k | 60k | 10.22 | |
| Accelr8 Technology | 0.4 | $623k | 30k | 20.77 | |
| Myovant Sciences | 0.4 | $622k | 50k | 12.44 | |
| SPDR S&P Biotech (XBI) | 0.3 | $592k | 10k | 59.20 | |
| Pacific Biosciences of California (PACB) | 0.3 | $570k | 150k | 3.80 | |
| Adma Biologics (ADMA) | 0.3 | $512k | 100k | 5.12 | |
| Adaptimmune Therapeutics (ADAP) | 0.2 | $405k | 100k | 4.05 | |
| Oncomed Pharmaceuticals | 0.2 | $386k | 50k | 7.72 | |
| Tandem Diabetes Care | 0.1 | $161k | 75k | 2.15 |
